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Abstract
Neutrophils play an important role in protecting against infection. Foals have age-dependent deficiencies in neutrophil
function that may contribute to their predisposition to infection. Thus, we investigated the ability of a CpG-ODN formulated
with Emulsigen to modulate functional responses of neutrophils in neonatal foals. Eighteen foals were randomly assigned to
receive either a CpG-ODN with Emulsigen (N= 9) or saline intramuscularly at ages 1 and 7 days. At ages 1, 3, 9, 14, and 28,
blood was collected and neutrophils were isolated from each foal. Neutrophils were assessed for basal and Rhodococcus
equi-stimulated mRNA expression of the cytokines interferon-c (IFN-c), interleukin (IL)-4, IL-6, and IL-8 using real-time PCR,
degranulation by quantifying the amount of b-D glucuronidase activity, and reactive oxygen species (ROS) generation using
flow cytometry. In vivo administration of the CpG-ODN formulation on days 1 and 7 resulted in significantly (P,0.05)
increased IFN-c mRNA expression by foal neutrophils on days 3, 9, and 14. Degranulation was significantly (P,0.05) lower
for foals in the CpG-ODN-treated group than the control group at days 3 and 14, but not at other days. No effect of
treatment on ROS generation was detected. These results indicate that CpG-ODN administration to foals might improve
innate and adaptive immune responses that could protect foals against infectious diseases and possibly improve responses
to vaccination.
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Introduction
Foals are known to be especially susceptible to a variety of
bacterial infections, including Rhodococcus equi, Salmonella,
Clostridium difficile and C. perfringens, and a number of Gram-
negative and Gram-positive organisms that are associated with
sepsis [1–7]. Consequently, pneumonia, diarrhea, and sepsis are
leading causes of death in young foals [8,9]. Neonatal susceptibility
to infectious diseases is attributable in part to their diminished
immune responses. Because neonatal adaptive immune responses
are relatively deficient and naı¨ve, newborns rely largely on innate
immune responses for protection against bacterial infections
[10,11].
Neutrophils are critical effector cells of innate immunity [11,12].
Neutrophils are the most abundant innate immune cells in blood,
and they play a role in linking innate and adaptive immunity by
recruiting and activating cells of the innate immune response.
Evidence exists that neutrophils play a protective role against
pathogens affecting neonates [10,11]. Our laboratory has demon-
strated the importance of neutrophils in protecting mice against
experimental infection with R. equi [13]. Moreover, foals with
relatively lower circulating neutrophil concentrations at 2 and 4
weeks of age were significantly more likely to subsequently develop
R. equi pneumonia than foals with higher concentrations [14].
As observed for adaptive immune responses, innate immune
responses also may be diminished in neonates [10,11]. Age-
dependent impairment of neutrophil function contributes to
neonatal susceptibility to infectious diseases [10,11,15]. Although
several studies indicate that foal neutrophils function similarly to
those of adults after accounting for the reduced opsonic capacity of
young foals relative to adults [16–19], there is increasing evidence
of deficiencies in functional responses of foals. Foal neutrophils
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have been demonstrated to have decreased bactericidal capacity
concurrent with reduced serum opsonic capacity [20,21]. Age-
related changes in basal and R. equi-stimulated cytokine gene
expression by foal neutrophils have been described [22–24]. If the
ability of neutrophils to protect foals against infections is
compromised during early life, enhancing the functional responses
of neutrophils in newborn foals might be an effective preventive
strategy because both innate and adaptive immune responses
could be impacted by such an approach.
Recently, our laboratory has demonstrated that stimulation in
vitro with a synthetic cytosine-phosphate guanine oligodeoxynu-
cleotide (CpG-ODN) could significantly increase pro-inflammato-
ry cytokine gene expression and degranulation of neutrophils
collected from foals as young as 1 day of age [23,24]. While
exciting, these results do not indicate whether administration of
CpG-ODNs in vivo can alter the functional responses of foal
neutrophils. Thus, the purpose of the study reported here was to
determine whether in vivo administration of CpG-ODNs intra-
muscularly (IM) in combination with an adjuvant to foals could
stimulate functional responses of foal neutrophils evaluated ex
vivo. The functional responses we investigated include production
of reactive oxygen species (ROS), cytokine gene expression, and
degranulation.
Materials and Methods
Ethics statement
All procedures for this study, including collection of blood
samples and administration of treatments to foals, were reviewed
and approved by the Texas A&M University Institutional Animal
Care and Use Committee (protocol number AUP # 2008-167)
and the Texas A&M University Institutional Biosafety Committee
(permit number 2008-109-Cohen). The foals used in this study
were owned by Texas A&M University, and permission for their
use was provided in compliance with the Institutional Animal Care
and Use Committee procedures.
Foals
Twenty-two healthy Quarter Horse foals were used for this
study. All foals were born healthy and had age-appropriate results
of complete blood count (CBC) on day 2 of life, and adequate
transfer of passive immunity as assessed by a commercially-
available qualitative immunoassay for serum concentration of total
IgG (SNAP Foal IgG test; IDEXX, Inc., Westbrook, ME, USA).
All foals were monitored daily by Texas A&M University Horse
Center staff for clinical signs of disease, and inspected at least twice
weekly by a veterinarian for clinical signs of disease. All foals
except 1 remained free of clinical signs of disease and in good
health throughout the study. One foal sustained musculoskeletal
trauma at approximately 2 weeks of age and was excluded from
the study. The respective dams of foals were fed 6.4 kg per horse
per day of a 13% horse pellet (crude protein: 13.5%; crude fat:
4.5%; crude fiber: 10%); the foals and their mares were allowed
free access to coastal Bermuda grass hay, plus grazing of pastures
at the Texas A&M University Horse Center where the mares were
maintained.
The foals were assigned randomly to 1 of 2 experimental groups
using a block design prior to birth. Foals in the control group
(N = 8) received 2.5 ml of sterile 0.9% sodium chloride solution
IM on days 1 and 7 after birth. Foals in the CpG group (N = 11; 1
foal excluded because of trauma that required extensive veterinary
care) received 2.5 mg of CpG-ODN 2142 (generously provided by
Merial, Ltd., Duluth, GA, USA) diluted in sterile saline in
combination with 1 ml of a commercial emulsifier (Emulsigen,
MVP Technologies, Omaha, NE, USA) for a total volume of
2.5 ml administered IM on days 1 and 7 after birth. The selection
of CpG-ODN 2142 was based on prior in vitro evidence of the
stimulatory effect of this CpG-ODN on foal leukocytes [24]. The
CpG-ODN was combined with Emulsigen because there is
extensive evidence that the combination of CpG-ODNs with
Emulsigen improves the immunomodulatory effects of CpG-
ODNs administered either when paired alone with Emulsigen or
when combined with Emulsigen and specific antigens in vaccines
[25–35]. On days 1, 3, 9, 14, and 28 after birth, approximately
60 ml of blood were collected into 8-ml tubes containing sodium
heparin as an anticoagulant (N = 5 tubes), 8-ml tubes containing a
clot activator (N = 2 tubes), and a 4-ml tube containing ethylene-
diaminetetraacetic acid (EDTA) as an anticoagulant; the latter
tube was used for determining a complete blood count. For
neutrophil isolation, whole blood was allowed to settle at room
temperature for 30 to 45 min, and then the plasma and buffy coat
layers were used for neutrophil purification as described previously
[22–24]. Neutrophils were isolated by layering whole blood over a
discontinuous Histopaque (Sigma-Aldrich, St. Louis, MO, USA)
gradient (specific gravity 1.077 over specific gravity 1.119), and
centrifuged (7006g, 30 min, room temperature). After centrifu-
gation, the 1.119 band containing the neutrophils was removed
and washed once with Hanks balanced salt solution (HBSS) and
centrifuged (3006g, 10 min). The neutrophil concentration was
determined using an automated cell counter (Cellometer Auto T4,
Nexcelcom, Lawrence, MA, USA), and purified neutrophils were
examined microscopically to determine purity (to confirm.98%
of neutrophils in the cell preparations). Neutrophils were then
resuspended in HBSS to a final concentration of 26107 cells/ml.
Cytokine mRNA expression
Freshly isolated neutrophils (approximately 56106/well) were
incubated in 1 ml RPMI medium, with or without stimulation
using live, virulent Rhodococcus equi (ATCC strain 33701) at a
modulus of infection of 10 bacteria to 1 neutrophil, in 12-well
tissue culture plates at 37uC in 5% CO2 in triplicate. After 2 h of
incubation, cells were harvested, and RNA extraction, DNase
treatment, and cDNA synthesis were carried out as described
previously [22–24]. Expression of mRNA of equine cytokines
(IFN-c, IL-4, IL-6, and IL-8) was measured using real-time
quantitative RT-PCR. These cytokines were selected on the basis
of results of in vitro effects of CpG-ODNs on foal neutrophils, 23 in
particular that IL-6 and IL-8 are abundantly expressed by
neutrophils; 22-24 IFN-c was selected because it is the prototypic
T helper 1-type cytokine and IL-4 is considered a prototypic T
helper 2-type cytokine. Absolute quantification of gene copy
number was conducted using the standard curve method.
Standard curves were constructed for each gene, by cloning the
corresponding equine cDNA gene sequence into a plasmid vector
(IFN-c, IL-4, IL-6, and IL-8) and transforming into chemically
competent E. coli. Plasmid DNA was extracted, and the accuracy
of the cloned sequence was confirmed through bi-directional
sequencing. The copy number of the plasmid standard was
calculated using the following formula: copies/ml = plasmid
concentration (g/ml)66.02261023/plasmid length (bp)6660. A
series of corresponding standards was prepared by performing 10-
fold serial dilutions of plasmid DNA in the range of 100 million to
0.1 copies per PCR reaction. Gene copy numbers for each target
gene were determined by comparison of the fluorescence
generated by each sample with standard curves of know quantities.
Primer and probe sequences for each gene tested were described in
Table S1. Primers were designed to span 2 exons to avoid
amplifying genomic DNA, and were further tested to document
CpG Foal Neutrophils
PLOS ONE | www.plosone.org 2 October 2014 | Volume 9 | Issue 10 | e109865
that they did not amplify genomic DNA by testing RNA
preparations with and without residual genomic DNA prior to
use. The PCR reactions were performed in optical 384-well plates
using a 7900HT Fast Real-Time PCR System (Applied Biosys-
tems, Foster City, CA, USA). Each 20-ml reaction mixture
contained 10 ml of 26TaqMan Universal Master Mix (Invitrogen,
Life Technologies, Grand Island, NY, USA), 60 ng cDNA,
400 nM each of forward and reverse primers, and 200 nM of
TaqMan probe (Applied Biosystems, Life Technologies, Grand
Island, NY, USA) and molecular grade water. The thermal profile
consisted of an initial hold at 50uC for 2 min, followed by a single
denaturation step at 95uC for 10 min, and then 40 cycles of 95uC
for 15 s, 60uC for 60 s. Samples were tested by PCR in duplicate
for each reaction.
Degranulation
Neutrophil degranulation was detected by quantifying the
amount of b-D glucuronidase activity in the culture medium
following stimulation of the neutrophils with opsonized R. equi
(ATCC 33701); serum from a mare with a high optical density of
anti-R. equi antibodies as determined by ELISA was used to
opsonize the R. equi. Rhodococcus equi was selected as a stimulus
on the basis of prior evidence of its effectiveness [22–24].
Neutrophils (16107 cells/ml) were incubated for 1 h on a rocker
platform at 37uC with live, virulent R. equi at an MOI of 10
bacteria per neutrophil (as for cytokine expression). The cells were
then centrifuged (2506g, 10 min, 4uC) and the resultant
supernatants were used for the assay. A 25-ml aliquot of each
supernatant was added to wells in a black flat-bottom ELISA plate
and incubated with 50 ml of substrate (10 mM 4-methylumbelli-
feryl-b-D-glucuronide, 0.1% Triton X-100 in 0.1 M sodium
acetate buffer) for 4 h at 37uC. The reaction was stopped by
adding 200 ml of stop solution (0.05 M glycine and 5 mM EDTA;
pH 10.4) to each well. Liberated 4-methylumbelliferone was
measured fluorometrically (excitation wavelength of 355 nm and
an emission wavelength of 460 nm) with a fluorometric plate
reader (BioTek Synergy 2, Winooski, VT, USA). These values
were converted to mmoles of 4-methylumbelliferone generated
using a standard curve of known concentrations.
ROS generation
To measure ROS production, whole blood leukocytes were
isolated by layering whole blood onto Ficoll-Paque, using 2 parts
blood and 1 part gradient. Erythrocytes were allowed to sediment
at room temperature for 30 min. The upper layer was removed
and washed once with 15 ml HBSS and centrifuged (3006g for
10 min, 4uC). Residual erythrocytes were lysed by the addition of
NH4Cl (pre-warmed to 37uC) and incubated at room temperature
for 3 min. Cells were centrifuged (3006g, 10 min, 4uC) and the
resultant leukocyte pellet was washed once with HBSS and
centrifuged (3006g, 10 min, 4uC). The leukocytes were re-
suspended in 1 ml HBSS and kept on ice until aliquoted for assay.
A 10 mg/ml stock solution of dihydrorhodamine-123 (DHR;
Sigma-Aldrich, St. Louis, MO, USA) was prepared in DMSO and
stored at220uC. This solution was diluted in HBSS to a 25 mg/ml
working solution and stored in the dark until use. For ROS
production, leukocytes (26106 cells) were incubated at 37uC with
2.5 mg DHR alone (negative control) or DHR + R. equi for
30 min; 80 ng of phorbol 12-myrisate 13-acetate (PMA) was used
as a positive control.
The number of reactive neutrophils and mean fluorescent
intensity was analyzed using a FACScan flow cytometer equipped
with a 488-mm argon laser and Cell Quest Analysis Software
(Beckton Dickinson, San Jose, CA, USA). Leukocyte subpopula-
tions were displayed in a dot plot and gated according to size and
granularity. A total of 10,000 data events were collected.
Data analysis
For each cytokine, exploratory data analysis was performed.
When the expression data were not normally distributed,
logarithmic (log10) transformation was performed to approximate
a normal distribution, as assessed using the Shapiro–Wilk test
statistic. Linear mixed-effects modeling was used for analysis of all
mRNA expression data, with individual foal modeled as a random
effect to account for repeated measures over time (ages), and age
was modeled as a fixed, ordered categorical effect. Linear mixed-
effects modeling also was used for analysis of the degranulation or
ROS data, with individual foal modeled as a random effect to
account for repeated measures over time (ages), stimulus modeled
as a categorical variable (with negative control as the reference
group) and age modeled as a fixed, ordered categorical effect. Post
hoc testing among times or stimuli was performed using the
method of Sidak. A significance level of P,0.05 was used for all
statistical analyses, which were performed using S-PLUS (version
8.1) statistical software (TIBCO, Seattle, WA, USA).
Results
Cytokine gene expression
The expression of IFN-c mRNA by neutrophils in response to
R. equi stimulation in vitro was significantly (P,0.05) associated
with age, and this effect was modulated by CpG-ODN treatment
(Figure 1). For foals in both groups, IFN-c mRNA expression in
response to R. equi increased with age. For foals in the CpG
group, values on days 1 and 3 were significantly (P,0.05) less than
those on days 9, 14, and 28. For foals in the control group,
however, values were only significantly different between day 28
and other days. At age 1 day, there was no significant difference in
R. equi-stimulated IFN-c expression between foals in the 2 groups;
however, at ages 3, 9, and 14 days, IFN-c mRNA expression was
significantly higher in the CpG group; by 28 days, there was no
significant difference between groups (Figure 1). Effects of
treatment depended on age: at day 1 and by day 28, there were
no significant differences between groups; however, on days 3, 9,
and 14, foals in the CpG group had significantly (P,0.05) greater
stimulated mRNA expression of IFN-c mRNA (Figure 1).
For IL-4, absolute copy numbers were low at all ages (Table 1).
Nevertheless, values of R. equi-induced significantly greater IL-4
on days 3, 9, 14, and 28 than on day 1 for foals in both groups;
however, there were no significant effects of treatment on
stimulated IL-4 mRNA expression between groups at any age
(Table 1). There were no significant effects of age or treatment on
expression of R. equi-stimulated mRNA expression of IL-6 or IL-8
(Table 2).
Degranulation
Degranulation responses decreased significantly (P,0.05) after
day 1 for foals of both groups (Figure 2). The effects of age varied
by treatment group: 4-methylumbelliferone concentration, an
indicator of degranulation, was significantly (P,0.05) lower for
foals in the CpG-ODN-treated group than the control group at
days 3 and 14, but not at other days.
ROS generation
Incubation with R. equi stimulated significant (P,0.0001)
increases, relative to unstimulated cells, in mean fluorescence
and in the number of reactive neutrophils. The number of
neutrophils in samples decreased with age, but there was no
CpG Foal Neutrophils
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significant effect of treatment on these age-related decreases
(Table 2). The number of reactive neutrophils also tended to
decreased with age (Table 2), but only values on day 3 differed
significantly from those observed on day 1, and there were no
significant effects of age (Table 2). There were no effects of age
or treatment on the mean fluorescence of neutrophils
(Table 2).
Discussion
Results of our study substantiate previous findings that blood
leukocytes in general [36–39] and neutrophils in particular [22–
24) express less IFN-c than older foals. It is plausible that reduced
IFN-c expression might diminish innate and adaptive immune
responses of neonatal foals, thereby rendering them more
susceptible to infectious diseases, and there is precedent for this
in other species. For example, reduced IFN-c expression by
Figure 1. Boxplots of log10 values of mRNA copy numbers by age and treatment group: blue boxes are data from the control
(saline) group and red boxes are data from the CpG-treated foals. The triangles in the middle of boxes represent the median value; the
bottom and top of the boxes represent the 25th and 75th percentiles, respectively. The vertical lines extending from the boxes to horizontal lines
represent multiples of 1.75 of the respective interquartile distance. Numbers above boxes represent within-treatment group differences among ages:
within treatment group, ages with different numbers differed significantly (P,0.05) between groups. Asterisks denote days on which values were
significantly (P,0.05) different between the control and Cp-G-treated foals. Arrows along the horizontal axis indicate ages when treatment (saline or
CpG) was administered.
doi:10.1371/journal.pone.0109865.g001
Table 1. Mean (and 95% confidence intervals) for mRNA copy numbers estimated by mixed-effects modeling for IL-4, IL-6, and IL-
8.
Cytokine Treatment Group Day 1 Day 3 Day 9 Day 14 Day 28
IL-4 Control 2 (1–5)a,1 11 (4–28)a,2 14 (6–35)a,2 25 (10–62)a,2 22 (9–56)a,2
CpG 4 (2–12)a,1 25 (11–60)a,2 32 (14–76)a,2 57 (24–135)a,2 52 (21–131)a,2
IL-6 Control 871a,1 (564–1,346) 1,256a,1 (816–1,934) 859a,1 (565–1,307) 888a,1 (581–1,358) 1,046a,1 (689–1,587)
CpG 1,041a,1 (688–1,575) 1,501a,1 (993–2,272) 1,027a,1 (679–1,554) 1,060a,1 (701–1,603) 1,250a,1 (826–1,891)
IL-8 Control 169,824a;1 (83,992–
343,368)
162,181a,1 (111,310–
236,300)
126,882a,1 (88,032–
182,877)
187,932a,1 (129,802–
272,095)
172,187a,1 (119,465–
248,176)
CpG 389,942a,1 (164,679–
923,336)
371,535a,1 (156,906–
879,752)
290,670a,1 (122,755–
688,272)
430,527a,1 (181,819–
1,019,436
394,457a,1 (166,587–
934,028)
Data represent back-transformed results of log10-transformed data. Values in columns with the same letter indicate absence of statistical significance between groups
for a given age. Values in rows with differing superscripted numbers indicate significant (P,0.05) differences among ages within group.
doi:10.1371/journal.pone.0109865.t001
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human neonatal cord blood monocytes in response to stimulation
with respiratory syncytial virus was associated with increased
cumulative incidence of viral respiratory tract disease during the
first year of life [40]). Moreover, pre-treatment of neonatal mice
with CpG-ODNs can increase IFN-c by circulating neonatal
natural killer (NK) cells, which are effector cells of innate immune
responses [41]. Expression of IFN-c by cells of the innate immune
system can contribute to driving Th-1-type immune responses that
are important for protecting against intracellular infections [42].
Innate immune responses to infection are important in neonates
for at least 2 reasons. First, neonates are generally immunolog-
ically naı¨ve at birth, and adaptive immune responses require time
for development [10–12]. Second, innate responses are the first-
line of defense against invading pathogens [10–12,42]. Conse-
quently, newborns rely heavily on innate immune responses for
protection against infection. Neutrophils play a crucial role in
innate immune responses: they are the most abundant immune
cells in circulation and are generally the first immune effector cells
to arrive at sites of infection. In addition to their primary
bactericidal role, neutrophils can produce cytokines that may
influence the development of adaptive immune responses [11,42].
Thus, production of IFN-c by neutrophils may contribute to
limiting infection and enhancing responses to vaccines. Infectious
diseases are leading causes of disease and death in foals [8,9].
Clinical evaluation of the role of CpG-ODNs for protecting
neonatal foals against infectious diseases is consequently warranted
on the basis of the results of this study. Many important details
regarding dosing will need to be considered for clinical use,
including the number of doses administered. In this study, the
CpG-ODN preparation was administered to foals at ages 1 and 7
days. The effects of the CpG-ODN preparation were apparent for
at least 7 days after the second dose; however, effects appeared to
have dissipated by 28 days of age. The duration of effects between
15 and 28 days of age of the regimen used in this study remains
undefined. Thus, further study will be needed to characterize the
duration of effects of the CpG-ODN and the number of doses
tailored to the critical period for protection of various infections.
The period of early life was of particular interest to us.
Although treatment had no effect on IL-4 mRNA expression by
neutrophils, expression of this cytokine increased significantly
between the day of birth and older ages. The clinical relevance of
this finding is unknown. Interleukin-4 is considered to be a
prototypical T helper (TH) 2-type cytokine, and neutrophils are
known to produce IL-4 in low amounts [43]. It has been proposed
that because neutrophils express the IL-4 receptor, they might be
responsive even to low levels of IL-4 [43], as was observed in this
study. Effects of IL-4 on neutrophils include stimulating differen-
tiation, activation, protein expression, and, in an inflammatory
milieu, enhanced respiratory burst activity and phagocytosis [44–
46].
Irrespective of treatment group, we observed that degranulation
appeared to be significantly higher on day 1 after birth relative to
all other ages. The clinical importance of this result is unknown,
but these results appear to suggest that neutrophils from 1-day-old
foals are more prone to degranulation. Degranulation is a
functional response of neutrophils that plays an important role
in host defenses against microorganisms. A wide range of
antimicrobial and potentially cytotoxic substances are contained
within neutrophil granules, including antimicrobial proteins,
proteases, components of the oxidative respiratory burst, mem-
brane-bound receptors for endothelial adhesion molecules, extra-
cellular matrix proteins, and soluble mediators of inflammation
[44,47]. Following degranulation, these substances are released to
the phagosome or to the exterior of the cell where they exert
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antimicrobial effects. The activity of the released enzymes, such as
myeloperoxidase, elastase, and b-D-glucuronidase (the azurophilic
granule enzyme marker used in this study), can be used to monitor
neutrophil degranulation. Conceivably, neutrophils of 1-day-old
foals being more prone to degranulation could be a host defense
mechanism designed to enhance innate immune responses of
newborn foals. Alternatively, the tendency to more readily
degranulate might represent a less mature, potentially noxious
response that predisposes newborn foals to exaggerated responses
to pathogens with deleterious results from releasing more granular
contents.
There were small and inconsistent but significant effects of the
administration of CpG-ODN 2142 on the degranulation of foal
neutrophils: although degranulation responses were similar among
foals in both treatment groups on day 1 of life, degranulation was
significantly less on days 3 and 14 for foals treated with CpG-
ODN 2142 compared to the control group. The interpretation of
these findings is unclear. Conceivably, treatment with the CpG-
ODN resulted in a more mature degranulation profile (i.e., less like
that of 1-day-old foals); teleologically, this might result in less
neutrophil-induced damage to the host’s own tissues in response to
invading micro-organisms. The magnitude of these effects were
small, however (particularly on day 14), and were not observed on
day 9. Thus, the clinical relevance of this observation remains
unclear. We used R. equi as a stimulus for degranulation, based on
previous results indicating that N-formyl-methionyl-leucyl-phenyl-
alanine (fMLP) was not effective at stimulating degranulation in
equine degranulation (20) and unpublished data from our
laboratory documenting that R. equi was an effective stimulus of
degranulation of foal neutrophils. It is possible that our findings
would have differed had we used either another stimulus for
degranulation or a different indicator of degranulation than b-D-
glucuronidase activity. Interestingly, in vitro stimulation with
CpG-ODN 2142 resulted in increased degranulation by neonatal
foal neutrophils [20]. The reason for this discrepancy is unclear
but may reflect either differences between in vitro and in vivo
administration of CpG-ODNs, or the effects of the emulsifying
adjuvant.
There were no significant effects of CpG-ODN administration
on ROS production as measured by the number of reactive
neutrophils or the mean fluorescence of neutrophils following in
vitro stimulation with R. equi. Our laboratory previously described
a priming effect of CpGs on in vitro stimulation of ROS
generation in neutrophils stimulated with fMLP priming [24].
Thus, it was disappointing that in vivo administration of CpGs
failed to enhance ROS production in response to ex vivo
stimulation of neutrophils with R. equi. The observation that
neutrophil concentrations decreased with age during the first
month of life is well established [48]. Thus, it was not surprising
that the total number of reactive neutrophils was significantly
lower on day 3 than day 1, and tended to be lower for other days.
Conceivably, the finding that the decrease in total neutrophils
appeared progressive with age whereas the number of reactive
neutrophils did not could represent a concomitant decrease in total
numbers and an increase in functional response with age.
This study had a number of limitations. We did not document
whether the increased expression of neutrophil IFN-c had any
effect on host susceptibility to infection. Foals in this study
remained healthy throughout the project. A larger study using
foals with either natural or experimental infections is needed to
Figure 2. Boxplots of values of liberated 4-methylumbelliferone (4-MU) measured fluorometrically by age and treatment group:
blue boxes are data from the control (saline) group and red boxes are data from the CpG-treated foal (see Figure 1 for boxplot
description). Numbers above boxes represent within-treatment group differences among ages: within treatment group, ages with different
numbers differed significantly (P,0.05) between groups. Asterisks denote days on which values were significantly (P,0.05) different between the
control and Cp-G-treated foals. Arrows along the horizontal axis indicate ages when treatment (saline or CpG was administered.
doi:10.1371/journal.pone.0109865.g002
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assess the role of CpG-ODN-induced expression of IFN-c by
neutrophils for protecting foals against infections. Such a study is
warranted because evidence exists to suggest that production of
IFN-c by neutrophils could protect against infection. Neutrophils
producing IFN-c have been demonstrated in mice during infection
with Salmonella, another intracellular pathogen [49]. Moreover,
neutrophil-derived IFN-c plays a role in protecting mice against
Listeria monocytogenes, a facultative, intracellular pathogen that
infects macrophages and other non-phagocytic cells [50]. Intra-
tracheal administration of CpG-ODNs has been demonstrated to
stimulate innate immune responses, including IFN-c expression
and IFN-c-mediated processes that protected mice against
experimentally-induced Klebsiella pneumonia [51].
Another limitation of our study is that we examined only the
combination of CpG-ODN 2142 with Emulsigen but did not
examine the effects of this CpG-ODN or the emulsifier
independently. Thus, we cannot be sure whether the observed
effects were attributable to the CpG-ODN alone, the emulsifying
adjuvant, or both. Our rationale for examining the combination
was 3-fold. First, we have previously documented in vitro that
CpG-ODN 2142 influences neutrophil function of neonatal foals
[23]. Second, there is extensive literature documenting enhanced
in vitro and in vivo activity of CpG when combined with
Emulsigen that is not attributable solely to the emulsifying
adjuvant [25–35]. For example, Alves et al. documented that
administration in vivo to pigs of CpG-ODN 2142 formulated with
Emulsigen significantly increased gene expression of interferon-
responsive genes by peripheral blood mononuclear cells relative to
CpGs formulated with phosphate buffered saline or a double-oil
emulsifier, or the adjuvant Montanide ISA 206 [25]. As another
example, Ioannu et al. demonstrated that a bovine herpesvirus-1
subunit vaccine generated significantly greater virus-neutralizing
antibodies and significantly greater protection against viral
challenge than when the vaccine was formulated with either
Emulsigen alone or CpGs alone [26]. Although CpG-ODNs are
known to be potent activators of innate immune responses, their
effects are often short-lived [34]. Emulsigen is considered to create
a depot at the site of injection resulting in prolonged release of the
CpG-ODNs from the injection site, thereby extending the
immune-activating effects of CpG-ODNs in the host [26,34].
Because of the improved immune activation from formulating
CpG-ODNs with Emulsigen, it seemed most clinically relevant
and appropriate to examine the combination. Third, we lacked an
adequate population of foals necessary to allow for adequate
statistical power to permit comparisons among 4 treatment groups
(viz., CpG-ODN 2142 alone, Emulsigen alone, Emulsigen + CpG-
ODN 2142, and saline [negative] control).
Despite these limitations, we believe the results of this study are
promising. Intramuscular administration of newborn foals with
CpG-ODN 2142 in combination with Emulsigen on the day of
birth and 1 week later resulted in a significant increase in R. equi-
stimulated IFN-c expression. Moreover, the CpG-ODN with
Emulsigen also appeared to modulate degranulation responses.
Further evaluation of the impact of these functional responses on
the susceptibility of neonates to infection and their ability to
respond to vaccines is warranted because infectious diseases are
major causes of disease and death in foals and other neonates
[8,9].
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